These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16416850)

  • 1. [Prostate cancer gene therapy].
    Nasu Y; Abarzua F; Kumon H
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():544-7. PubMed ID: 16416850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene therapy for glioma].
    Mizuno M; Yoshida J
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():562-5. PubMed ID: 16416853
    [No Abstract]   [Full Text] [Related]  

  • 3. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
    Hattori Y; Maitani Y
    Cancer Gene Ther; 2005 Oct; 12(10):796-809. PubMed ID: 15891776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy for leukemia].
    Kaneko S; Onodera M; Nagasawa T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():637-40. PubMed ID: 16416866
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for prostate cancer.
    Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy for ovarian cancer].
    Hamada K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():552-61. PubMed ID: 16416852
    [No Abstract]   [Full Text] [Related]  

  • 8. [All-trans retinoic acid enhances bystander effect of suicide-gene therapy against androgen-unresponsive prostate cancer].
    Chen WG; Yan CY; Hou JQ; Wen DG; Pu JX; Wang HB
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):122-5. PubMed ID: 18390175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suicide gene and immuno gene therapy for prostate cancer].
    Nasu Y; Sasaki K; Kumon H; Kaku H; Watanabe M
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():554-8. PubMed ID: 22208043
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.
    Colombo F; Barzon L; Franchin E; Pacenti M; Pinna V; Danieli D; Zanusso M; Palù G
    Cancer Gene Ther; 2005 Oct; 12(10):835-48. PubMed ID: 15891772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
    Nakaya H
    Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suicide gene therapy for prostate cancer--update of current development].
    Ebara S; Nasu Y
    Nihon Rinsho; 2003 Jul; 61(7):1257-65. PubMed ID: 12877094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
    Shalev M; Kadmon D; Teh BS; Butler EB; Aguilar-Cordova E; Thompson TC; Herman JR; Adler HL; Scardino PT; Miles BJ
    J Urol; 2000 Jun; 163(6):1747-50. PubMed ID: 10799174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
    Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
    Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy for malignant brain tumors--the present conditions and the prospects].
    Nakahara N; Yoshida J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():499-503. PubMed ID: 16201571
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for prostate cancer.
    Hrouda D; Perry M; Dalgleish AG
    Semin Oncol; 1999 Aug; 26(4):455-71. PubMed ID: 10482188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene therapy].
    Gotoh A; Shirakawa T; Wada Y; Hinata N; Terao S; Hara I; Arakawa S; Kamidono S; Okada H; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2005 Feb; 51(2):75-9. PubMed ID: 15773357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
    Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
    Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different approaches of gene therapy used in prostate cancer.
    Ghosh A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):103-11. PubMed ID: 16171569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.